Skip to content

Effects of Postoperative Patient-Controlled Intravenous Oliceridine Infusion on Postoperative Gastrointestinal Function Recovery in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

Effects of Postoperative Patient-Controlled Intravenous Oliceridine Infusion on Postoperative Gastrointestinal Function Recovery in Patients Undergoing Laparoscopic Colorectal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127183
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Gastrointestinal Dysfunction

Interventions

Oliceridine analgesic pump group:Patient-controlled intravenous analgesia (PCIA): Oliceridine 0.4 mg/kg plus tropisetron 6 mg diluted with normal saline to a final volume of 100 mL. A
Sufentanil analgesic pump group:Patient-controlled intravenous analgesia (PCIA): Sufentanil 2 µg/kg and tropisetron 6 mg are diluted with normal saline to a total volume of 100 mL. A

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for laparoscopic colorectal cancer surgery under general anesthesia; 2. Age 45 years and above, but not exceeding 80 years; 3. ASA classification: grades I - III; 4. BMI 18-30 kg/m^2; 5. Patients who received patient-controlled intravenous analgesia after the operation.

Exclusion criteria

Exclusion criteria: 1. Allergy to drugs used during anesthesia and postoperative analgesia; 2. History of chronic pain or long-term use of opioid drugs; 3. Long-term use of psychotropic drugs or history of drug abuse; 4. Complicated with severe respiratory diseases, severe cardiovascular and cerebrovascular diseases, or severe liver and kidney dysfunction; 5. Had a surgical history in the last 3 months, and previously undergone colorectal surgery; 6. Suspected intestinal obstruction; 7. Has participated in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Time to first postoperative flatus;

Secondary

MeasureTime frame
Time to first postoperative defecation;Postoperative pain numerical rating scale (NRS) scores;Postoperative Gastrointestinal Function Score (I-FEED);Quality of postoperative recovery;Incidence of postoperative adverse reactions;Time to first ambulation;Number of patient-controlled analgesia pump bolus requests within 24 hours postoperatively;Time to first oral feeding;

Countries

China

Contacts

Public ContactXiuxia Chen

The Affiliated Hospital of Xuzhou Medical University

cxxlxy@sina.com+86 516 85802297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026